RE:RE:RE:RE:Medical Advisor Endocrinology United StatesThere is a market for HIV patients having both lipodystrophy and NAFLD/NASH. After Grinspoon's results we thought Thera would be able to get more patients with both conditions, but it did not materialized. So maybe this new position is an effort to educate HIV doctors with patients having lipo/NAFLD at the same time. These patients would have insurance because they have lipo, both could benefit from Egrifta for NAFLD/NASH at the same time.
Wino115 wrote: I had the same thought as you. I just can't imagine there will be many doctors who will use it like Grinspoon has for his patients. The cost, whether insurance will cover you for NAFLD use, not on label, scientific lit on the light side, etc.. It seems like a longshot. I guess to cover salary and expenses you'd need a dozen or so prescriptions a year added for NAFLD. Can't really be worth bothering with unless you think you can get hundreds of new patients on it.